Generative AI In Healthcare Market To Reach $14.77 Billion By 2030

Generative AI In Healthcare Market Growth & Trends

The global generative AI in healthcare market size is expected to reach USD 14.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a compound annual growth rate (CAGR) of 36.7% from 2023 to 2030. Generative models in healthcare are advancing diagnostic accuracy by generating high-resolution medical images. These AI-powered models excel at producing intricate imaging, aiding in the detection and diagnosis of critical diseases like cancer, lesions, and abnormalities. The enhanced image quality enables healthcare professionals to identify subtle anomalies more effectively. Moreover, the efficiency and speed of generative models expedite the diagnostic process, enabling prompt intervention and improved patient outcomes.

Generative AI is utilized in drug discovery to create new drug compounds or optimize the existing ones, accelerating the drug development timeline. Additionally, it assists in predicting drug properties and potential side effects, offering valuable insights for informed decision-making in the pharmaceutical industry. For instance, DeepChem, an open-source platform created by Stanford University researchers, employs generative models and machine learning to drive advancements in computational chemistry for drug discovery. DeepChem offers a range of tools and models to optimize and analyze molecular compounds, catering to diverse applications in healthcare and pharmaceutical industries.

Generative AI is a transformative force in healthcare, enabling a profound shift towards personalized medicine. By leveraging an individual's genetic data and health history, generative AI algorithms can craft tailor-made treatment plans and medications. This innovative approach ensures that medical interventions are precisely aligned with a person's unique genetic makeup and health circumstances, maximizing treatment efficacy and minimizing adverse effects. The potential of generative AI to customize healthcare interventions marks a pivotal advancement in medicine, promising a future where treatments are optimized and personalized for everyone, ultimately improving overall healthcare outcomes.

Generative AI's foothold in the healthcare market of North America has strengthened significantly, showcasing a notable surge in growth. Advances in artificial intelligence and machine learning, particularly generative models, have propelled their applications within healthcare. From generating medical images for accurate diagnostics to aiding drug discovery processes, and personalizing treatment plans based on individual genetic profiles, the potential of generative AI is being actively explored and adopted. Collaborations between research institutions, healthcare organizations, and technology firms, along with substantial venture capital funding and supportive regulatory frameworks, further fuel the integration of generative AI into various healthcare domains. The demand for personalized medicine and a drive towards innovation are key factors contributing to the remarkable growth of generative AI in the healthcare sector throughout North America.

 Request a free sample copy or view report summary: Generative AI In Healthcare Market Report

Generative AI In Healthcare Market Report Highlights

• Based on function, the medical imaging analysis segment dominated with a revenue share of 28.9% in 2022. Generative models, such as Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs), have shown significant promise in generating high-fidelity medical images

• Based on end-use, the clinical research segment dominated the market with a revenue share of 29.3% in 2022. Generative AI has demonstrated substantial potential in assisting and expediting various aspects of clinical research like drug discovery, optimization of clinical trial designs, predictive analytics, and optimizing research processes

• The pharmaceutical industry continued to embrace generative AI for drug discovery and development. AI-driven generative models accelerated the process of identifying potential drug candidates and optimizing existing ones, reducing the time and cost associated with bringing new medications to market

• Generative AI is revolutionizing healthcare training with realistic virtual simulations. It helps create lifelike patient avatars and interactive surgical scenarios, enhancing the skills of healthcare professionals in a risk-free environment

Generative AI In Healthcare Market Segmentation

Grand View Research has segmented the global generative AI in healthcare market based on component, function, end-use, application, and region:

Generative AI In Healthcare Component Outlook (Revenue, USD Million, 2017 - 2030)

• Solutions

• Service

Generative AI In Healthcare Function Outlook (Revenue, USD Million, 2017 - 2030)

• Virtual Nursing Assistants

• Robot-Assisted AI Surgery

• Administrative Process Optimization

• Medical Imaging Analysis

Generative AI In Healthcare End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Clinical Research

• Medical Centers

• Diagnostic Centers

• Others

Generative AI In Healthcare Application Outlook (Revenue, USD Million, 2017 - 2030)

• Clinical

• System

Generative AI In Healthcare Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

• Middle East and Africa

  • KSA

  • UAE

  • South Africa

List of Key Players in the Generative AI In Healthcare Market

• Google LLC

• IBM Watson

• Johnson & Johnson

• Microsoft Corporation

• Neuralink Corporation

• NioyaTech

• OpenAI

• Oracle

• Saxon

• Syntegra

• Tencent Holdings Ltd